Loading clinical trials...
Loading clinical trials...
This is an 8-week, multicenter, open-label study in which eligible subjects with a history of otitis media requiring TT placement will receive 6 mg OTO-201 to each ear. The study is designed to evalua...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Otonomy, Inc.
NCT07242001 · Otitis Media With Effusion
NCT06034080 · Acute Otitis Media, Ear Infection, and more
NCT06505330 · Otitis Media in Children, Cleft Palate Children
NCT06316635 · Microplastics, Otitis Media With Effusion, and more
NCT06285812 · Otitis Media Acute
Email Otonomy Central Contact for Trial Locations
San Diego, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions